Screener
Artiva Biotherapeutics, Inc. ARTV Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 6:40 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213242
| Line item | AS OF / MARCH 31,2026 | AS OF / DECEMBER 31,2025 |
|---|---|---|
| Accounts payable | $2,286 | $355 |
| Accrued expenses (including related party amounts of $4 and $0, respectively) | 5,559 | 9,600 |
| Current portion of operating lease liabilities | 3,024 | 3,015 |
| Current portion of financing lease liability | 11 | 44 |
| Other current liabilities | — | 73 |
| Total current liabilities | 10,880 | 13,087 |
| Operating lease liabilities, net of current portion | 7,228 | 7,883 |
| Total liabilities | 18,108 | 20,970 |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s current debt?
- Artiva Biotherapeutics, Inc. (ARTV) reported current debt of $11K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s current debt changed year-over-year?
- Artiva Biotherapeutics, Inc.'s current debt decreased by 91.3% year-over-year, from $126K to $11K.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Artiva Biotherapeutics, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude